Literature DB >> 8878615

Glycylcyclines bind to the high-affinity tetracycline ribosomal binding site and evade Tet(M)- and Tet(O)-mediated ribosomal protection.

J Bergeron1, M Ammirati, D Danley, L James, M Norcia, J Retsema, C A Strick, W G Su, J Sutcliffe, L Wondrack.   

Abstract

N,N-dimethylglycylamido (DMG) derivatives of 6-demethyl-6-deoxytetracycline and doxycycline bind 5-fold more effectively than tetracycline to the tetracycline high-affinity binding site on the Escherichia coli 70S ribosome, which correlates with a 10-fold increase in potency for inhibition of E. coli cell-free translation. The potencies of DMG-doxycycline and DMG-6-demethyl-6-deoxytetracycline were unaffected by the ribosomal tetracycline resistance factors Tet(M) and Tet(O) in cell-free translation assays and whole-cell bioassays with a conditional Tet(M)-producing E. coli strain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8878615      PMCID: PMC163507     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

1.  Inhibition of protein synthesis occurring on tetracycline-resistant, TetM-protected ribosomes by a novel class of tetracyclines, the glycylcyclines.

Authors:  B A Rasmussen; Y Gluzman; F P Tally
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

2.  Streptococcal tetracycline resistance mediated at the level of protein synthesis.

Authors:  V Burdett
Journal:  J Bacteriol       Date:  1986-02       Impact factor: 3.490

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Effect of mutational alteration of Asn-128 in the putative GTP-binding domain of tetracycline resistance determinant Tet(O) from Campylobacter jejuni.

Authors:  J Grewal; E K Manavathu; D E Taylor
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

5.  Characterization and expression of a cloned tetracycline resistance determinant from Campylobacter jejuni plasmid pUA466.

Authors:  D E Taylor; K Hiratsuka; H Ray; E K Manavathu
Journal:  J Bacteriol       Date:  1987-07       Impact factor: 3.490

6.  Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.

Authors:  F W Studier; B A Moffatt
Journal:  J Mol Biol       Date:  1986-05-05       Impact factor: 5.469

7.  Evaluation of three 4"-deoxy-4"-sulfonamido-oleandomycin derivatives with erythromycin-like antibacterial potency.

Authors:  A R English; J A Retsema; A E Girard; W Schelkly; J E Lynch
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

8.  A novel glycylcycline, 9-(N,N-dimethylglycylamido)-6-demethyl-6-deoxytetracycline, is neither transported nor recognized by the transposon Tn10-encoded metal-tetracycline/H+ antiporter.

Authors:  Y Someya; A Yamaguchi; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

9.  "Glycylcyclines". 3. 9-Aminodoxycyclinecarboxamides.

Authors:  T C Barden; B L Buckwalter; R T Testa; P J Petersen; V J Lee
Journal:  J Med Chem       Date:  1994-09-30       Impact factor: 7.446

10.  Glycylcyclines. 1. A new generation of potent antibacterial agents through modification of 9-aminotetracyclines.

Authors:  P E Sum; V J Lee; R T Testa; J J Hlavka; G A Ellestad; J D Bloom; Y Gluzman; F P Tally
Journal:  J Med Chem       Date:  1994-01-07       Impact factor: 7.446

View more
  33 in total

1.  Antipneumococcal activities of GAR-936 (a new glycylcycline) compared to those of nine other agents against penicillin-susceptible and -resistant pneumococci.

Authors:  D B Hoellman; G A Pankuch; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

Review 2.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 3.  Systematic review and meta-analysis of the effectiveness and safety of tigecycline for treatment of infectious disease.

Authors:  Yun Cai; Rui Wang; Beibei Liang; Nan Bai; Youning Liu
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

4.  Antibiotic drug tigecycline reduces neuroblastoma cells proliferation by inhibiting Akt activation in vitro and in vivo.

Authors:  Xiaoxia Zhong; Erhu Zhao; Chunling Tang; Weibo Zhang; Juan Tan; Zhen Dong; Han-Fei Ding; Hongjuan Cui
Journal:  Tumour Biol       Date:  2015-12-19

Review 5.  Tigecycline.

Authors:  James E Frampton; Monique P Curran
Journal:  Drugs       Date:  2005       Impact factor: 9.546

6.  Functional, biophysical, and structural bases for antibacterial activity of tigecycline.

Authors:  Matthew W Olson; Alexey Ruzin; Eric Feyfant; Thomas S Rush; John O'Connell; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

7.  Cryo-EM structure of the tetracycline resistance protein TetM in complex with a translating ribosome at 3.9-Å resolution.

Authors:  Stefan Arenz; Fabian Nguyen; Roland Beckmann; Daniel N Wilson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

8.  The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria.

Authors:  J Barrett Deris; Minsu Kim; Zhongge Zhang; Hiroyuki Okano; Rutger Hermsen; Alexander Groisman; Terence Hwa
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

Review 9.  Newer antibacterial drugs for a new century.

Authors:  Gina Devasahayam; William M Scheld; Paul S Hoffman
Journal:  Expert Opin Investig Drugs       Date:  2010-02       Impact factor: 6.206

Review 10.  The evolving role of chemical synthesis in antibacterial drug discovery.

Authors:  Peter M Wright; Ian B Seiple; Andrew G Myers
Journal:  Angew Chem Int Ed Engl       Date:  2014-07-02       Impact factor: 15.336

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.